Open-house discount agreements for Dorzolamid ATR (EDO) 2026-11

Summary

The tender concerns an open-house discount agreement for the medicine Dorzolamid ATR (EDO) under the relevant lot. The contracting authorities aim to conclude uniform discount agreements with all suitable pharmaceutical companies. There are no individual negotiations, no exclusivity, and accession is possible at any time during the contract period. The contract term is generally up to 20 months, starting no earlier than 1 August 2026 and ending no later than 31 March 2028, depending on the lot.